Cargando…

Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria

Both nosocomial pathogens, such as Streptococcus pneumoniae and Haemophilus influenzae and food-borne pathogens, such as Bacillus cereus and Clostridium perfringens are known to be detrimental to human and animal health. The effectiveness of currently used treatments for these pathogens becomes limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Tahl, Lacal, Juan Carlos, Ibrahim, Salam A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813931/
https://www.ncbi.nlm.nih.gov/pubmed/31681254
http://dx.doi.org/10.3389/fmicb.2019.02146
_version_ 1783462926832631808
author Zimmerman, Tahl
Lacal, Juan Carlos
Ibrahim, Salam A.
author_facet Zimmerman, Tahl
Lacal, Juan Carlos
Ibrahim, Salam A.
author_sort Zimmerman, Tahl
collection PubMed
description Both nosocomial pathogens, such as Streptococcus pneumoniae and Haemophilus influenzae and food-borne pathogens, such as Bacillus cereus and Clostridium perfringens are known to be detrimental to human and animal health. The effectiveness of currently used treatments for these pathogens becomes limited as resistant strains emerge. Therefore, new methods for eliminating bacterial pathogens must be developed continuously. This includes establishing novel targets to which drug discovery efforts could be focused. A promising method for discovering new drug targets in prokaryotes is to take advantage of the information available regarding the enzymatic pathways that have been established as drug targets in eukaryotic systems and explore the analogous pathways found in bacterial systems. This is an efficient strategy because the same inhibitors developed at considerable expense to block these pathways in eukaryotic systems could also be employed in prokaryotes. Drugs that are used to prevent diseases involving eukaryotic cells could be repurposed as antibiotics and antimicrobials for the control of bacteria pathogens. This strategy could be pursued whenever the primary and tertiary structures of a target are are conserved between eukaryotic and prokaryotes. A possible novel target fitting these parameters is choline kinase (ChoK), whose active site sequences are conserved (Figure 1) and whose tertiary structure (Figure 2) is maintained. Here, we describe why ChoK is a putative drug target by describing its role in the growth and pathogenesis of Gram-positive bacteria S. pneumoniae and the Gram-negative bacteria H. influenzae. Using S. pneumoniae as a model, we also present promising preliminary information that repurposing of drugs known to inhibit the human isoform of ChoK (hChoK), is a promising strategy for blocking the growth of S. pneumoniae cells and inhibiting the activity of the S. pneumoniae isoform of ChoK (sChok), with downstream physiological effects on the cell wall.
format Online
Article
Text
id pubmed-6813931
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68139312019-11-01 Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria Zimmerman, Tahl Lacal, Juan Carlos Ibrahim, Salam A. Front Microbiol Microbiology Both nosocomial pathogens, such as Streptococcus pneumoniae and Haemophilus influenzae and food-borne pathogens, such as Bacillus cereus and Clostridium perfringens are known to be detrimental to human and animal health. The effectiveness of currently used treatments for these pathogens becomes limited as resistant strains emerge. Therefore, new methods for eliminating bacterial pathogens must be developed continuously. This includes establishing novel targets to which drug discovery efforts could be focused. A promising method for discovering new drug targets in prokaryotes is to take advantage of the information available regarding the enzymatic pathways that have been established as drug targets in eukaryotic systems and explore the analogous pathways found in bacterial systems. This is an efficient strategy because the same inhibitors developed at considerable expense to block these pathways in eukaryotic systems could also be employed in prokaryotes. Drugs that are used to prevent diseases involving eukaryotic cells could be repurposed as antibiotics and antimicrobials for the control of bacteria pathogens. This strategy could be pursued whenever the primary and tertiary structures of a target are are conserved between eukaryotic and prokaryotes. A possible novel target fitting these parameters is choline kinase (ChoK), whose active site sequences are conserved (Figure 1) and whose tertiary structure (Figure 2) is maintained. Here, we describe why ChoK is a putative drug target by describing its role in the growth and pathogenesis of Gram-positive bacteria S. pneumoniae and the Gram-negative bacteria H. influenzae. Using S. pneumoniae as a model, we also present promising preliminary information that repurposing of drugs known to inhibit the human isoform of ChoK (hChoK), is a promising strategy for blocking the growth of S. pneumoniae cells and inhibiting the activity of the S. pneumoniae isoform of ChoK (sChok), with downstream physiological effects on the cell wall. Frontiers Media S.A. 2019-10-15 /pmc/articles/PMC6813931/ /pubmed/31681254 http://dx.doi.org/10.3389/fmicb.2019.02146 Text en Copyright © 2019 Zimmerman, Lacal and Ibrahim. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Zimmerman, Tahl
Lacal, Juan Carlos
Ibrahim, Salam A.
Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria
title Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria
title_full Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria
title_fullStr Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria
title_full_unstemmed Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria
title_short Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria
title_sort choline kinase emerges as a promising drug target in gram-positive bacteria
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813931/
https://www.ncbi.nlm.nih.gov/pubmed/31681254
http://dx.doi.org/10.3389/fmicb.2019.02146
work_keys_str_mv AT zimmermantahl cholinekinaseemergesasapromisingdrugtargetingrampositivebacteria
AT lacaljuancarlos cholinekinaseemergesasapromisingdrugtargetingrampositivebacteria
AT ibrahimsalama cholinekinaseemergesasapromisingdrugtargetingrampositivebacteria